nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—SLC22A5—Dactinomycin—skin cancer	0.0775	0.114	CbGbCtD
Valproic Acid—SLC22A7—Fluorouracil—skin cancer	0.0702	0.104	CbGbCtD
Valproic Acid—CYP1A2—Imiquimod—skin cancer	0.0618	0.0911	CbGbCtD
Valproic Acid—CYP2C8—Vismodegib—skin cancer	0.0553	0.0816	CbGbCtD
Valproic Acid—SLC22A7—Docetaxel—skin cancer	0.0536	0.079	CbGbCtD
Valproic Acid—CYP2C19—Vismodegib—skin cancer	0.0464	0.0684	CbGbCtD
Valproic Acid—CYP2A6—Fluorouracil—skin cancer	0.0399	0.0588	CbGbCtD
Valproic Acid—CYP2C9—Vismodegib—skin cancer	0.0386	0.0569	CbGbCtD
Valproic Acid—CYP1A2—Vemurafenib—skin cancer	0.0339	0.0499	CbGbCtD
Valproic Acid—CYP3A4—Temozolomide—skin cancer	0.0324	0.0477	CbGbCtD
Valproic Acid—CYP3A4—Imiquimod—skin cancer	0.0324	0.0477	CbGbCtD
Valproic Acid—CYP1A2—Dacarbazine—skin cancer	0.026	0.0383	CbGbCtD
Valproic Acid—CYP3A4—Vismodegib—skin cancer	0.0224	0.0331	CbGbCtD
Valproic Acid—CYP2C8—Fluorouracil—skin cancer	0.0197	0.029	CbGbCtD
Valproic Acid—CYP3A4—Vemurafenib—skin cancer	0.0177	0.0262	CbGbCtD
Valproic Acid—CYP3A5—Docetaxel—skin cancer	0.0156	0.023	CbGbCtD
Valproic Acid—CYP1A2—Fluorouracil—skin cancer	0.0152	0.0224	CbGbCtD
Valproic Acid—CYP2C9—Fluorouracil—skin cancer	0.0137	0.0202	CbGbCtD
Valproic Acid—CYP3A4—Docetaxel—skin cancer	0.00609	0.00897	CbGbCtD
Valproic Acid—ACADSB—nipple—skin cancer	0.0026	0.0489	CbGeAlD
Valproic Acid—OGDH—connective tissue—skin cancer	0.00232	0.0437	CbGeAlD
Valproic Acid—ALDH5A1—nipple—skin cancer	0.00229	0.0431	CbGeAlD
Valproic Acid—HDAC2—hair follicle—skin cancer	0.00218	0.0409	CbGeAlD
Valproic Acid—OGDH—lymphoid tissue—skin cancer	0.0017	0.0319	CbGeAlD
Valproic Acid—OGDH—female reproductive system—skin cancer	0.00164	0.0308	CbGeAlD
Valproic Acid—ACADSB—mammalian vulva—skin cancer	0.00152	0.0286	CbGeAlD
Valproic Acid—HDAC9—lymphoid tissue—skin cancer	0.0015	0.0282	CbGeAlD
Valproic Acid—UGT2B15—female reproductive system—skin cancer	0.00148	0.0278	CbGeAlD
Valproic Acid—UGT1A8—head—skin cancer	0.00147	0.0277	CbGeAlD
Valproic Acid—HDAC2—neck—skin cancer	0.00146	0.0275	CbGeAlD
Valproic Acid—HDAC9—female reproductive system—skin cancer	0.00144	0.0272	CbGeAlD
Valproic Acid—OGDH—head—skin cancer	0.00137	0.0257	CbGeAlD
Valproic Acid—ACADSB—female reproductive system—skin cancer	0.0013	0.0245	CbGeAlD
Valproic Acid—HDAC9—head—skin cancer	0.00121	0.0227	CbGeAlD
Valproic Acid—ALDH5A1—lymphoid tissue—skin cancer	0.00119	0.0223	CbGeAlD
Valproic Acid—ALDH5A1—female reproductive system—skin cancer	0.00115	0.0215	CbGeAlD
Valproic Acid—CYP2C18—mammalian vulva—skin cancer	0.00114	0.0215	CbGeAlD
Valproic Acid—HDAC2—connective tissue—skin cancer	0.00105	0.0197	CbGeAlD
Valproic Acid—HDAC2—epithelium—skin cancer	0.000994	0.0187	CbGeAlD
Valproic Acid—OGDH—lymph node—skin cancer	0.000958	0.018	CbGeAlD
Valproic Acid—ALDH5A1—head—skin cancer	0.000957	0.018	CbGeAlD
Valproic Acid—HDAC2—skin of body—skin cancer	0.000945	0.0178	CbGeAlD
Valproic Acid—UGT2B7—female reproductive system—skin cancer	0.000902	0.017	CbGeAlD
Valproic Acid—SLC16A1—epithelium—skin cancer	0.000883	0.0166	CbGeAlD
Valproic Acid—PTGS1—endothelium—skin cancer	0.000882	0.0166	CbGeAlD
Valproic Acid—HDAC9—lymph node—skin cancer	0.000845	0.0159	CbGeAlD
Valproic Acid—ABAT—head—skin cancer	0.000819	0.0154	CbGeAlD
Valproic Acid—PTGS1—blood vessel—skin cancer	0.000814	0.0153	CbGeAlD
Valproic Acid—HDAC2—lymphoid tissue—skin cancer	0.000765	0.0144	CbGeAlD
Valproic Acid—ACADSB—lymph node—skin cancer	0.000761	0.0143	CbGeAlD
Valproic Acid—SLC22A5—nipple—skin cancer	0.000749	0.0141	CbGeAlD
Valproic Acid—HDAC2—female reproductive system—skin cancer	0.000738	0.0139	CbGeAlD
Valproic Acid—CYP1A2—nipple—skin cancer	0.000679	0.0128	CbGeAlD
Valproic Acid—ALDH5A1—lymph node—skin cancer	0.00067	0.0126	CbGeAlD
Valproic Acid—SLC16A1—female reproductive system—skin cancer	0.000656	0.0123	CbGeAlD
Valproic Acid—HDAC2—head—skin cancer	0.000617	0.0116	CbGeAlD
Valproic Acid—PTGS1—nipple—skin cancer	0.000588	0.0111	CbGeAlD
Valproic Acid—ABAT—lymph node—skin cancer	0.000573	0.0108	CbGeAlD
Valproic Acid—SLC16A1—head—skin cancer	0.000548	0.0103	CbGeAlD
Valproic Acid—SLC22A5—skin of body—skin cancer	0.00048	0.00902	CbGeAlD
Valproic Acid—HDAC2—lymph node—skin cancer	0.000432	0.00812	CbGeAlD
Valproic Acid—PTGS1—connective tissue—skin cancer	0.000417	0.00785	CbGeAlD
Valproic Acid—CYP2B6—skin of body—skin cancer	0.000417	0.00784	CbGeAlD
Valproic Acid—SLC22A8—head—skin cancer	0.000414	0.00779	CbGeAlD
Valproic Acid—PTGS1—epithelium—skin cancer	0.000396	0.00745	CbGeAlD
Valproic Acid—SLC16A1—lymph node—skin cancer	0.000384	0.00722	CbGeAlD
Valproic Acid—PTGS1—skin of body—skin cancer	0.000377	0.00709	CbGeAlD
Valproic Acid—SLC22A5—female reproductive system—skin cancer	0.000375	0.00705	CbGeAlD
Valproic Acid—CYP2C8—female reproductive system—skin cancer	0.000363	0.00682	CbGeAlD
Valproic Acid—PTGS1—mammalian vulva—skin cancer	0.000344	0.00646	CbGeAlD
Valproic Acid—CYP2B6—lymphoid tissue—skin cancer	0.000337	0.00635	CbGeAlD
Valproic Acid—CYP2B6—female reproductive system—skin cancer	0.000325	0.00612	CbGeAlD
Valproic Acid—CYP2C9—female reproductive system—skin cancer	0.000322	0.00606	CbGeAlD
Valproic Acid—PTGS1—female reproductive system—skin cancer	0.000294	0.00553	CbGeAlD
Valproic Acid—CYP2B6—head—skin cancer	0.000272	0.00511	CbGeAlD
Valproic Acid—Mediastinal disorder—Temozolomide—skin cancer	0.000247	0.000957	CcSEcCtD
Valproic Acid—Cough—Bleomycin—skin cancer	0.000247	0.000956	CcSEcCtD
Valproic Acid—PTGS1—head—skin cancer	0.000246	0.00462	CbGeAlD
Valproic Acid—CYP3A4—female reproductive system—skin cancer	0.000246	0.00462	CbGeAlD
Valproic Acid—Chills—Temozolomide—skin cancer	0.000246	0.000953	CcSEcCtD
Valproic Acid—Ill-defined disorder—Dactinomycin—skin cancer	0.000244	0.000948	CcSEcCtD
Valproic Acid—Anaemia—Dactinomycin—skin cancer	0.000244	0.000944	CcSEcCtD
Valproic Acid—Vomiting—Vemurafenib—skin cancer	0.000242	0.000938	CcSEcCtD
Valproic Acid—Alopecia—Temozolomide—skin cancer	0.000242	0.000938	CcSEcCtD
Valproic Acid—Dry skin—Docetaxel—skin cancer	0.000241	0.000936	CcSEcCtD
Valproic Acid—Myalgia—Bleomycin—skin cancer	0.000241	0.000933	CcSEcCtD
Valproic Acid—Chest pain—Bleomycin—skin cancer	0.000241	0.000933	CcSEcCtD
Valproic Acid—Orthostatic hypotension—Docetaxel—skin cancer	0.00024	0.000932	CcSEcCtD
Valproic Acid—Abdominal pain upper—Docetaxel—skin cancer	0.00024	0.000932	CcSEcCtD
Valproic Acid—Rash—Vemurafenib—skin cancer	0.00024	0.000931	CcSEcCtD
Valproic Acid—Mental disorder—Temozolomide—skin cancer	0.00024	0.00093	CcSEcCtD
Valproic Acid—Dermatitis—Vemurafenib—skin cancer	0.00024	0.00093	CcSEcCtD
Valproic Acid—Hypersensitivity—Imiquimod—skin cancer	0.000239	0.000927	CcSEcCtD
Valproic Acid—Headache—Vemurafenib—skin cancer	0.000238	0.000925	CcSEcCtD
Valproic Acid—Malnutrition—Temozolomide—skin cancer	0.000238	0.000924	CcSEcCtD
Valproic Acid—Breast disorder—Docetaxel—skin cancer	0.000238	0.000922	CcSEcCtD
Valproic Acid—Discomfort—Bleomycin—skin cancer	0.000238	0.000922	CcSEcCtD
Valproic Acid—Malaise—Dactinomycin—skin cancer	0.000238	0.000922	CcSEcCtD
Valproic Acid—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000237	0.000919	CcSEcCtD
Valproic Acid—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000237	0.000919	CcSEcCtD
Valproic Acid—Leukopenia—Dactinomycin—skin cancer	0.000236	0.000915	CcSEcCtD
Valproic Acid—Dysgeusia—Temozolomide—skin cancer	0.000233	0.000905	CcSEcCtD
Valproic Acid—Asthenia—Imiquimod—skin cancer	0.000233	0.000903	CcSEcCtD
Valproic Acid—Confusional state—Bleomycin—skin cancer	0.000232	0.000902	CcSEcCtD
Valproic Acid—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000232	0.0009	CcSEcCtD
Valproic Acid—Oedema—Bleomycin—skin cancer	0.000231	0.000894	CcSEcCtD
Valproic Acid—Anaphylactic shock—Bleomycin—skin cancer	0.000231	0.000894	CcSEcCtD
Valproic Acid—Back pain—Temozolomide—skin cancer	0.000231	0.000894	CcSEcCtD
Valproic Acid—Pruritus—Imiquimod—skin cancer	0.00023	0.000891	CcSEcCtD
Valproic Acid—Infection—Bleomycin—skin cancer	0.000229	0.000888	CcSEcCtD
Valproic Acid—Dysphagia—Docetaxel—skin cancer	0.000227	0.000882	CcSEcCtD
Valproic Acid—Nausea—Vemurafenib—skin cancer	0.000226	0.000877	CcSEcCtD
Valproic Acid—Thrombocytopenia—Bleomycin—skin cancer	0.000226	0.000876	CcSEcCtD
Valproic Acid—Arrhythmia—Fluorouracil—skin cancer	0.000225	0.000874	CcSEcCtD
Valproic Acid—Vision blurred—Temozolomide—skin cancer	0.000225	0.000871	CcSEcCtD
Valproic Acid—Myalgia—Dactinomycin—skin cancer	0.000224	0.00087	CcSEcCtD
Valproic Acid—Tremor—Temozolomide—skin cancer	0.000223	0.000866	CcSEcCtD
Valproic Acid—Alopecia—Fluorouracil—skin cancer	0.000223	0.000864	CcSEcCtD
Valproic Acid—Diarrhoea—Imiquimod—skin cancer	0.000222	0.000861	CcSEcCtD
Valproic Acid—Discomfort—Dactinomycin—skin cancer	0.000222	0.00086	CcSEcCtD
Valproic Acid—Ill-defined disorder—Temozolomide—skin cancer	0.000221	0.000858	CcSEcCtD
Valproic Acid—Anaemia—Temozolomide—skin cancer	0.00022	0.000854	CcSEcCtD
Valproic Acid—Anorexia—Bleomycin—skin cancer	0.00022	0.000852	CcSEcCtD
Valproic Acid—SLC22A5—lymph node—skin cancer	0.000219	0.00412	CbGeAlD
Valproic Acid—Agitation—Temozolomide—skin cancer	0.000219	0.000849	CcSEcCtD
Valproic Acid—Angioedema—Temozolomide—skin cancer	0.000218	0.000845	CcSEcCtD
Valproic Acid—Pancytopenia—Docetaxel—skin cancer	0.000216	0.000838	CcSEcCtD
Valproic Acid—Hypotension—Bleomycin—skin cancer	0.000215	0.000836	CcSEcCtD
Valproic Acid—Oedema—Dactinomycin—skin cancer	0.000215	0.000834	CcSEcCtD
Valproic Acid—Malaise—Temozolomide—skin cancer	0.000215	0.000833	CcSEcCtD
Valproic Acid—Dizziness—Imiquimod—skin cancer	0.000215	0.000832	CcSEcCtD
Valproic Acid—Vertigo—Temozolomide—skin cancer	0.000214	0.00083	CcSEcCtD
Valproic Acid—Infection—Dactinomycin—skin cancer	0.000214	0.000829	CcSEcCtD
Valproic Acid—Leukopenia—Temozolomide—skin cancer	0.000213	0.000827	CcSEcCtD
Valproic Acid—Neutropenia—Docetaxel—skin cancer	0.000213	0.000825	CcSEcCtD
Valproic Acid—Palpitations—Temozolomide—skin cancer	0.000211	0.000817	CcSEcCtD
Valproic Acid—Thrombocytopenia—Dactinomycin—skin cancer	0.000211	0.000817	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00021	0.000815	CcSEcCtD
Valproic Acid—Cough—Temozolomide—skin cancer	0.000208	0.000807	CcSEcCtD
Valproic Acid—Paraesthesia—Bleomycin—skin cancer	0.000207	0.000803	CcSEcCtD
Valproic Acid—Weight increased—Docetaxel—skin cancer	0.000207	0.000803	CcSEcCtD
Valproic Acid—Vision blurred—Fluorouracil—skin cancer	0.000207	0.000803	CcSEcCtD
Valproic Acid—Vomiting—Imiquimod—skin cancer	0.000206	0.0008	CcSEcCtD
Valproic Acid—Weight decreased—Docetaxel—skin cancer	0.000206	0.000798	CcSEcCtD
Valproic Acid—Hypertension—Temozolomide—skin cancer	0.000206	0.000798	CcSEcCtD
Valproic Acid—Dyspnoea—Bleomycin—skin cancer	0.000206	0.000797	CcSEcCtD
Valproic Acid—Anorexia—Dactinomycin—skin cancer	0.000205	0.000795	CcSEcCtD
Valproic Acid—Rash—Imiquimod—skin cancer	0.000205	0.000794	CcSEcCtD
Valproic Acid—Dermatitis—Imiquimod—skin cancer	0.000204	0.000793	CcSEcCtD
Valproic Acid—Pneumonia—Docetaxel—skin cancer	0.000204	0.000791	CcSEcCtD
Valproic Acid—Headache—Imiquimod—skin cancer	0.000203	0.000789	CcSEcCtD
Valproic Acid—Anaemia—Fluorouracil—skin cancer	0.000203	0.000787	CcSEcCtD
Valproic Acid—Arthralgia—Temozolomide—skin cancer	0.000203	0.000787	CcSEcCtD
Valproic Acid—Myalgia—Temozolomide—skin cancer	0.000203	0.000787	CcSEcCtD
Valproic Acid—Anxiety—Temozolomide—skin cancer	0.000202	0.000784	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000202	0.000781	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000201	0.00078	CcSEcCtD
Valproic Acid—Discomfort—Temozolomide—skin cancer	0.0002	0.000777	CcSEcCtD
Valproic Acid—Decreased appetite—Bleomycin—skin cancer	0.0002	0.000777	CcSEcCtD
Valproic Acid—Dry mouth—Temozolomide—skin cancer	0.000198	0.00077	CcSEcCtD
Valproic Acid—Stomatitis—Docetaxel—skin cancer	0.000198	0.000767	CcSEcCtD
Valproic Acid—Pain—Bleomycin—skin cancer	0.000197	0.000765	CcSEcCtD
Valproic Acid—Conjunctivitis—Docetaxel—skin cancer	0.000197	0.000765	CcSEcCtD
Valproic Acid—Leukopenia—Fluorouracil—skin cancer	0.000197	0.000762	CcSEcCtD
Valproic Acid—Confusional state—Temozolomide—skin cancer	0.000196	0.000761	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000196	0.00076	CcSEcCtD
Valproic Acid—Anaphylactic shock—Temozolomide—skin cancer	0.000195	0.000754	CcSEcCtD
Valproic Acid—Oedema—Temozolomide—skin cancer	0.000195	0.000754	CcSEcCtD
Valproic Acid—Infection—Temozolomide—skin cancer	0.000193	0.000749	CcSEcCtD
Valproic Acid—Nausea—Imiquimod—skin cancer	0.000193	0.000748	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Docetaxel—skin cancer	0.000192	0.000744	CcSEcCtD
Valproic Acid—Epistaxis—Docetaxel—skin cancer	0.000191	0.000742	CcSEcCtD
Valproic Acid—Nervous system disorder—Temozolomide—skin cancer	0.000191	0.00074	CcSEcCtD
Valproic Acid—Thrombocytopenia—Temozolomide—skin cancer	0.00019	0.000739	CcSEcCtD
Valproic Acid—Feeling abnormal—Bleomycin—skin cancer	0.00019	0.000737	CcSEcCtD
Valproic Acid—Agranulocytosis—Docetaxel—skin cancer	0.000189	0.000734	CcSEcCtD
Valproic Acid—Skin disorder—Temozolomide—skin cancer	0.000189	0.000733	CcSEcCtD
Valproic Acid—Hyperhidrosis—Temozolomide—skin cancer	0.000188	0.000729	CcSEcCtD
Valproic Acid—Chest pain—Fluorouracil—skin cancer	0.000187	0.000725	CcSEcCtD
Valproic Acid—Myalgia—Fluorouracil—skin cancer	0.000187	0.000725	CcSEcCtD
Valproic Acid—Decreased appetite—Dactinomycin—skin cancer	0.000187	0.000725	CcSEcCtD
Valproic Acid—Fatigue—Dactinomycin—skin cancer	0.000185	0.000719	CcSEcCtD
Valproic Acid—Anorexia—Temozolomide—skin cancer	0.000185	0.000719	CcSEcCtD
Valproic Acid—Discomfort—Fluorouracil—skin cancer	0.000185	0.000716	CcSEcCtD
Valproic Acid—Pain—Dactinomycin—skin cancer	0.000184	0.000713	CcSEcCtD
Valproic Acid—Urticaria—Bleomycin—skin cancer	0.000183	0.00071	CcSEcCtD
Valproic Acid—Haemoglobin—Docetaxel—skin cancer	0.000183	0.00071	CcSEcCtD
Valproic Acid—Rhinitis—Docetaxel—skin cancer	0.000183	0.000708	CcSEcCtD
Valproic Acid—Body temperature increased—Bleomycin—skin cancer	0.000182	0.000707	CcSEcCtD
Valproic Acid—Haemorrhage—Docetaxel—skin cancer	0.000182	0.000706	CcSEcCtD
Valproic Acid—Hypoaesthesia—Docetaxel—skin cancer	0.000181	0.000703	CcSEcCtD
Valproic Acid—Confusional state—Fluorouracil—skin cancer	0.000181	0.000701	CcSEcCtD
Valproic Acid—Pharyngitis—Docetaxel—skin cancer	0.000181	0.000701	CcSEcCtD
Valproic Acid—Urinary tract disorder—Docetaxel—skin cancer	0.00018	0.000697	CcSEcCtD
Valproic Acid—Oedema peripheral—Docetaxel—skin cancer	0.000179	0.000696	CcSEcCtD
Valproic Acid—Anaphylactic shock—Fluorouracil—skin cancer	0.000179	0.000695	CcSEcCtD
Valproic Acid—Oedema—Fluorouracil—skin cancer	0.000179	0.000695	CcSEcCtD
Valproic Acid—Connective tissue disorder—Docetaxel—skin cancer	0.000179	0.000694	CcSEcCtD
Valproic Acid—Urethral disorder—Docetaxel—skin cancer	0.000178	0.000692	CcSEcCtD
Valproic Acid—Infection—Fluorouracil—skin cancer	0.000178	0.00069	CcSEcCtD
Valproic Acid—Feeling abnormal—Dactinomycin—skin cancer	0.000177	0.000687	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000177	0.000687	CcSEcCtD
Valproic Acid—Insomnia—Temozolomide—skin cancer	0.000176	0.000682	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Dactinomycin—skin cancer	0.000176	0.000682	CcSEcCtD
Valproic Acid—Nervous system disorder—Fluorouracil—skin cancer	0.000176	0.000682	CcSEcCtD
Valproic Acid—Thrombocytopenia—Fluorouracil—skin cancer	0.000175	0.00068	CcSEcCtD
Valproic Acid—Visual impairment—Docetaxel—skin cancer	0.000175	0.00068	CcSEcCtD
Valproic Acid—Tachycardia—Fluorouracil—skin cancer	0.000175	0.000678	CcSEcCtD
Valproic Acid—Paraesthesia—Temozolomide—skin cancer	0.000175	0.000677	CcSEcCtD
Valproic Acid—Dyspnoea—Temozolomide—skin cancer	0.000173	0.000673	CcSEcCtD
Valproic Acid—Somnolence—Temozolomide—skin cancer	0.000173	0.000671	CcSEcCtD
Valproic Acid—Erythema multiforme—Docetaxel—skin cancer	0.000172	0.000668	CcSEcCtD
Valproic Acid—PTGS1—lymph node—skin cancer	0.000172	0.00324	CbGeAlD
Valproic Acid—Dyspepsia—Temozolomide—skin cancer	0.000171	0.000664	CcSEcCtD
Valproic Acid—Anorexia—Fluorouracil—skin cancer	0.000171	0.000662	CcSEcCtD
Valproic Acid—Eye disorder—Docetaxel—skin cancer	0.00017	0.00066	CcSEcCtD
Valproic Acid—Abdominal pain—Dactinomycin—skin cancer	0.00017	0.000659	CcSEcCtD
Valproic Acid—Body temperature increased—Dactinomycin—skin cancer	0.00017	0.000659	CcSEcCtD
Valproic Acid—Hypersensitivity—Bleomycin—skin cancer	0.00017	0.000659	CcSEcCtD
Valproic Acid—Decreased appetite—Temozolomide—skin cancer	0.000169	0.000656	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Temozolomide—skin cancer	0.000168	0.000651	CcSEcCtD
Valproic Acid—Fatigue—Temozolomide—skin cancer	0.000168	0.00065	CcSEcCtD
Valproic Acid—Hypotension—Fluorouracil—skin cancer	0.000167	0.000649	CcSEcCtD
Valproic Acid—Pain—Temozolomide—skin cancer	0.000166	0.000645	CcSEcCtD
Valproic Acid—Constipation—Temozolomide—skin cancer	0.000166	0.000645	CcSEcCtD
Valproic Acid—Asthenia—Bleomycin—skin cancer	0.000165	0.000642	CcSEcCtD
Valproic Acid—Angiopathy—Docetaxel—skin cancer	0.000165	0.000641	CcSEcCtD
Valproic Acid—Immune system disorder—Docetaxel—skin cancer	0.000164	0.000638	CcSEcCtD
Valproic Acid—Mediastinal disorder—Docetaxel—skin cancer	0.000164	0.000636	CcSEcCtD
Valproic Acid—Chills—Docetaxel—skin cancer	0.000163	0.000634	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000163	0.000633	CcSEcCtD
Valproic Acid—Pruritus—Bleomycin—skin cancer	0.000163	0.000633	CcSEcCtD
Valproic Acid—Arrhythmia—Docetaxel—skin cancer	0.000163	0.000631	CcSEcCtD
Valproic Acid—Insomnia—Fluorouracil—skin cancer	0.000162	0.000629	CcSEcCtD
Valproic Acid—Paraesthesia—Fluorouracil—skin cancer	0.000161	0.000624	CcSEcCtD
Valproic Acid—Alopecia—Docetaxel—skin cancer	0.000161	0.000624	CcSEcCtD
Valproic Acid—Feeling abnormal—Temozolomide—skin cancer	0.00016	0.000622	CcSEcCtD
Valproic Acid—Dyspnoea—Fluorouracil—skin cancer	0.00016	0.00062	CcSEcCtD
Valproic Acid—Mental disorder—Docetaxel—skin cancer	0.00016	0.000619	CcSEcCtD
Valproic Acid—Somnolence—Fluorouracil—skin cancer	0.000159	0.000618	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Temozolomide—skin cancer	0.000159	0.000617	CcSEcCtD
Valproic Acid—Malnutrition—Docetaxel—skin cancer	0.000158	0.000615	CcSEcCtD
Valproic Acid—Hypersensitivity—Dactinomycin—skin cancer	0.000158	0.000614	CcSEcCtD
Valproic Acid—Dyspepsia—Fluorouracil—skin cancer	0.000158	0.000612	CcSEcCtD
Valproic Acid—Decreased appetite—Fluorouracil—skin cancer	0.000156	0.000604	CcSEcCtD
Valproic Acid—Dysgeusia—Docetaxel—skin cancer	0.000155	0.000602	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000155	0.0006	CcSEcCtD
Valproic Acid—Urticaria—Temozolomide—skin cancer	0.000155	0.000599	CcSEcCtD
Valproic Acid—Asthenia—Dactinomycin—skin cancer	0.000154	0.000598	CcSEcCtD
Valproic Acid—Abdominal pain—Temozolomide—skin cancer	0.000154	0.000596	CcSEcCtD
Valproic Acid—Body temperature increased—Temozolomide—skin cancer	0.000154	0.000596	CcSEcCtD
Valproic Acid—Back pain—Docetaxel—skin cancer	0.000153	0.000595	CcSEcCtD
Valproic Acid—Pain—Fluorouracil—skin cancer	0.000153	0.000594	CcSEcCtD
Valproic Acid—Muscle spasms—Docetaxel—skin cancer	0.000152	0.000591	CcSEcCtD
Valproic Acid—Feeling abnormal—Fluorouracil—skin cancer	0.000148	0.000573	CcSEcCtD
Valproic Acid—Diarrhoea—Dactinomycin—skin cancer	0.000147	0.000571	CcSEcCtD
Valproic Acid—Vomiting—Bleomycin—skin cancer	0.000147	0.000569	CcSEcCtD
Valproic Acid—Anaemia—Docetaxel—skin cancer	0.000146	0.000568	CcSEcCtD
Valproic Acid—Rash—Bleomycin—skin cancer	0.000145	0.000564	CcSEcCtD
Valproic Acid—Dermatitis—Bleomycin—skin cancer	0.000145	0.000563	CcSEcCtD
Valproic Acid—Hypersensitivity—Temozolomide—skin cancer	0.000143	0.000556	CcSEcCtD
Valproic Acid—Urticaria—Fluorouracil—skin cancer	0.000142	0.000552	CcSEcCtD
Valproic Acid—Leukopenia—Docetaxel—skin cancer	0.000142	0.00055	CcSEcCtD
Valproic Acid—Body temperature increased—Fluorouracil—skin cancer	0.000142	0.000549	CcSEcCtD
Valproic Acid—Palpitations—Docetaxel—skin cancer	0.00014	0.000543	CcSEcCtD
Valproic Acid—Asthenia—Temozolomide—skin cancer	0.00014	0.000541	CcSEcCtD
Valproic Acid—Cough—Docetaxel—skin cancer	0.000138	0.000536	CcSEcCtD
Valproic Acid—Pruritus—Temozolomide—skin cancer	0.000138	0.000534	CcSEcCtD
Valproic Acid—Nausea—Bleomycin—skin cancer	0.000137	0.000531	CcSEcCtD
Valproic Acid—Hypertension—Docetaxel—skin cancer	0.000137	0.000531	CcSEcCtD
Valproic Acid—Vomiting—Dactinomycin—skin cancer	0.000137	0.00053	CcSEcCtD
Valproic Acid—Rash—Dactinomycin—skin cancer	0.000136	0.000526	CcSEcCtD
Valproic Acid—Arthralgia—Docetaxel—skin cancer	0.000135	0.000523	CcSEcCtD
Valproic Acid—Chest pain—Docetaxel—skin cancer	0.000135	0.000523	CcSEcCtD
Valproic Acid—Myalgia—Docetaxel—skin cancer	0.000135	0.000523	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000134	0.00052	CcSEcCtD
Valproic Acid—Diarrhoea—Temozolomide—skin cancer	0.000133	0.000516	CcSEcCtD
Valproic Acid—Hypersensitivity—Fluorouracil—skin cancer	0.000132	0.000512	CcSEcCtD
Valproic Acid—Dry mouth—Docetaxel—skin cancer	0.000132	0.000512	CcSEcCtD
Valproic Acid—Confusional state—Docetaxel—skin cancer	0.00013	0.000506	CcSEcCtD
Valproic Acid—Oedema—Docetaxel—skin cancer	0.000129	0.000502	CcSEcCtD
Valproic Acid—Anaphylactic shock—Docetaxel—skin cancer	0.000129	0.000502	CcSEcCtD
Valproic Acid—Dizziness—Temozolomide—skin cancer	0.000129	0.000499	CcSEcCtD
Valproic Acid—Infection—Docetaxel—skin cancer	0.000129	0.000498	CcSEcCtD
Valproic Acid—Nausea—Dactinomycin—skin cancer	0.000128	0.000495	CcSEcCtD
Valproic Acid—Nervous system disorder—Docetaxel—skin cancer	0.000127	0.000492	CcSEcCtD
Valproic Acid—Pruritus—Fluorouracil—skin cancer	0.000127	0.000492	CcSEcCtD
Valproic Acid—Thrombocytopenia—Docetaxel—skin cancer	0.000127	0.000491	CcSEcCtD
Valproic Acid—Tachycardia—Docetaxel—skin cancer	0.000126	0.00049	CcSEcCtD
Valproic Acid—Skin disorder—Docetaxel—skin cancer	0.000126	0.000487	CcSEcCtD
Valproic Acid—Vomiting—Temozolomide—skin cancer	0.000124	0.00048	CcSEcCtD
Valproic Acid—Anorexia—Docetaxel—skin cancer	0.000123	0.000478	CcSEcCtD
Valproic Acid—Rash—Temozolomide—skin cancer	0.000123	0.000476	CcSEcCtD
Valproic Acid—Diarrhoea—Fluorouracil—skin cancer	0.000123	0.000476	CcSEcCtD
Valproic Acid—Dermatitis—Temozolomide—skin cancer	0.000123	0.000475	CcSEcCtD
Valproic Acid—Headache—Temozolomide—skin cancer	0.000122	0.000473	CcSEcCtD
Valproic Acid—Hypotension—Docetaxel—skin cancer	0.000121	0.000469	CcSEcCtD
Valproic Acid—Dizziness—Fluorouracil—skin cancer	0.000119	0.00046	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000118	0.000457	CcSEcCtD
Valproic Acid—Insomnia—Docetaxel—skin cancer	0.000117	0.000454	CcSEcCtD
Valproic Acid—Paraesthesia—Docetaxel—skin cancer	0.000116	0.00045	CcSEcCtD
Valproic Acid—Nausea—Temozolomide—skin cancer	0.000116	0.000448	CcSEcCtD
Valproic Acid—Dyspnoea—Docetaxel—skin cancer	0.000115	0.000447	CcSEcCtD
Valproic Acid—Somnolence—Docetaxel—skin cancer	0.000115	0.000446	CcSEcCtD
Valproic Acid—Vomiting—Fluorouracil—skin cancer	0.000114	0.000442	CcSEcCtD
Valproic Acid—Dyspepsia—Docetaxel—skin cancer	0.000114	0.000442	CcSEcCtD
Valproic Acid—Rash—Fluorouracil—skin cancer	0.000113	0.000438	CcSEcCtD
Valproic Acid—Dermatitis—Fluorouracil—skin cancer	0.000113	0.000438	CcSEcCtD
Valproic Acid—Decreased appetite—Docetaxel—skin cancer	0.000112	0.000436	CcSEcCtD
Valproic Acid—Headache—Fluorouracil—skin cancer	0.000112	0.000435	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Docetaxel—skin cancer	0.000112	0.000433	CcSEcCtD
Valproic Acid—Fatigue—Docetaxel—skin cancer	0.000112	0.000432	CcSEcCtD
Valproic Acid—Pain—Docetaxel—skin cancer	0.000111	0.000429	CcSEcCtD
Valproic Acid—Constipation—Docetaxel—skin cancer	0.000111	0.000429	CcSEcCtD
Valproic Acid—Feeling abnormal—Docetaxel—skin cancer	0.000107	0.000413	CcSEcCtD
Valproic Acid—Nausea—Fluorouracil—skin cancer	0.000106	0.000413	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Docetaxel—skin cancer	0.000106	0.00041	CcSEcCtD
Valproic Acid—Abdominal pain—Docetaxel—skin cancer	0.000102	0.000397	CcSEcCtD
Valproic Acid—Body temperature increased—Docetaxel—skin cancer	0.000102	0.000397	CcSEcCtD
Valproic Acid—Hypersensitivity—Docetaxel—skin cancer	9.53e-05	0.00037	CcSEcCtD
Valproic Acid—Asthenia—Docetaxel—skin cancer	9.28e-05	0.00036	CcSEcCtD
Valproic Acid—Pruritus—Docetaxel—skin cancer	9.15e-05	0.000355	CcSEcCtD
Valproic Acid—Diarrhoea—Docetaxel—skin cancer	8.85e-05	0.000343	CcSEcCtD
Valproic Acid—Dizziness—Docetaxel—skin cancer	8.55e-05	0.000332	CcSEcCtD
Valproic Acid—Vomiting—Docetaxel—skin cancer	8.22e-05	0.000319	CcSEcCtD
Valproic Acid—Rash—Docetaxel—skin cancer	8.16e-05	0.000316	CcSEcCtD
Valproic Acid—Dermatitis—Docetaxel—skin cancer	8.15e-05	0.000316	CcSEcCtD
Valproic Acid—CYP2A6—Fluoropyrimidine Activity—ERCC2—skin cancer	8.15e-05	0.0078	CbGpPWpGaD
Valproic Acid—Headache—Docetaxel—skin cancer	8.1e-05	0.000314	CcSEcCtD
Valproic Acid—SLC22A5—SLC-mediated transmembrane transport—SLC12A2—skin cancer	8.06e-05	0.00771	CbGpPWpGaD
Valproic Acid—PTGS1—Overview of nanoparticle effects—PTGS2—skin cancer	8.03e-05	0.00769	CbGpPWpGaD
Valproic Acid—HDAC2—Regulation of Telomerase—TERT—skin cancer	7.88e-05	0.00755	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—MLH1—skin cancer	7.79e-05	0.00746	CbGpPWpGaD
Valproic Acid—Nausea—Docetaxel—skin cancer	7.68e-05	0.000298	CcSEcCtD
Valproic Acid—OGDH—Metabolism—PLIN2—skin cancer	7.58e-05	0.00726	CbGpPWpGaD
Valproic Acid—ALDH5A1—Transmission across Chemical Synapses—BRAF—skin cancer	7.57e-05	0.00725	CbGpPWpGaD
Valproic Acid—SLC22A8—SLC-mediated transmembrane transport—SLC12A2—skin cancer	7.28e-05	0.00698	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—CSPG4—skin cancer	7.19e-05	0.00688	CbGpPWpGaD
Valproic Acid—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—skin cancer	6.92e-05	0.00663	CbGpPWpGaD
Valproic Acid—PTGS1—Eicosanoid Synthesis—PTGS2—skin cancer	6.66e-05	0.00638	CbGpPWpGaD
Valproic Acid—HDAC2—Regulation of nuclear SMAD2/3 signaling—CDK4—skin cancer	6.13e-05	0.00587	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—CSPG4—skin cancer	6.11e-05	0.00585	CbGpPWpGaD
Valproic Acid—HDAC2—NoRC negatively regulates rRNA expression—ERCC2—skin cancer	6.08e-05	0.00582	CbGpPWpGaD
Valproic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC12A2—skin cancer	6.08e-05	0.00582	CbGpPWpGaD
Valproic Acid—HDAC2—Negative epigenetic regulation of rRNA expression—ERCC2—skin cancer	5.94e-05	0.00569	CbGpPWpGaD
Valproic Acid—HDAC2—RNA Polymerase I Promoter Clearance—ERCC2—skin cancer	5.94e-05	0.00569	CbGpPWpGaD
Valproic Acid—HDAC2—RNA Polymerase I Transcription—ERCC2—skin cancer	5.85e-05	0.0056	CbGpPWpGaD
Valproic Acid—ALDH5A1—Neuronal System—BRAF—skin cancer	5.8e-05	0.00555	CbGpPWpGaD
Valproic Acid—ABAT—Transmission across Chemical Synapses—BRAF—skin cancer	5.74e-05	0.00549	CbGpPWpGaD
Valproic Acid—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—skin cancer	5.57e-05	0.00534	CbGpPWpGaD
Valproic Acid—SLC22A7—Fluoropyrimidine Activity—TP53—skin cancer	5.41e-05	0.00519	CbGpPWpGaD
Valproic Acid—HDAC2—Epigenetic regulation of gene expression—ERCC2—skin cancer	5.27e-05	0.00505	CbGpPWpGaD
Valproic Acid—HDAC2—Cell Cycle—CDK4—skin cancer	5.1e-05	0.00489	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—ENO2—skin cancer	4.89e-05	0.00468	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—CSPG4—skin cancer	4.77e-05	0.00457	CbGpPWpGaD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—SLC12A2—skin cancer	4.76e-05	0.00456	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling by NOTCH—TP53—skin cancer	4.75e-05	0.00454	CbGpPWpGaD
Valproic Acid—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—skin cancer	4.74e-05	0.00454	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—PLIN2—skin cancer	4.68e-05	0.00449	CbGpPWpGaD
Valproic Acid—HDAC2—RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription—ERCC2—skin cancer	4.67e-05	0.00447	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—PTCH2—skin cancer	4.41e-05	0.00422	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—SLC12A2—skin cancer	4.4e-05	0.00422	CbGpPWpGaD
Valproic Acid—ABAT—Neuronal System—BRAF—skin cancer	4.4e-05	0.00421	CbGpPWpGaD
Valproic Acid—PTGS1—Overview of nanoparticle effects—IL6—skin cancer	4.38e-05	0.00419	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—ENO2—skin cancer	4.15e-05	0.00398	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PLIN2—skin cancer	4.09e-05	0.00392	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—SLC12A2—skin cancer	4.09e-05	0.00392	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—RHOU—skin cancer	3.92e-05	0.00375	CbGpPWpGaD
Valproic Acid—HDAC2—Cell Cycle—CDKN2A—skin cancer	3.9e-05	0.00373	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—CSPG4—skin cancer	3.78e-05	0.00362	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—FOXO4—skin cancer	3.74e-05	0.00358	CbGpPWpGaD
Valproic Acid—PTGS1—Arachidonic acid metabolism—PTGS2—skin cancer	3.7e-05	0.00355	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.7e-05	0.00355	CbGpPWpGaD
Valproic Acid—ALDH5A1—Transmission across Chemical Synapses—HRAS—skin cancer	3.48e-05	0.00333	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PLIN2—skin cancer	3.42e-05	0.00327	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.4e-05	0.00326	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—GLI2—skin cancer	3.34e-05	0.0032	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—CSPG4—skin cancer	3.3e-05	0.00316	CbGpPWpGaD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—IL6—skin cancer	3.26e-05	0.00312	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—ENO2—skin cancer	3.25e-05	0.00311	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—SHH—skin cancer	3.25e-05	0.00311	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MC1R—skin cancer	3.19e-05	0.00305	CbGpPWpGaD
Valproic Acid—SLC16A1—Cell surface interactions at the vascular wall—NRAS—skin cancer	3.18e-05	0.00304	CbGpPWpGaD
Valproic Acid—HDAC2—Transcription—ERCC2—skin cancer	3.16e-05	0.00303	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—GLI1—skin cancer	3.14e-05	0.00301	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.09e-05	0.00296	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—SUFU—skin cancer	2.98e-05	0.00285	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—CDK4—skin cancer	2.96e-05	0.00284	CbGpPWpGaD
Valproic Acid—CYP2A6—Fluoropyrimidine Activity—TP53—skin cancer	2.91e-05	0.00278	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—ERCC2—skin cancer	2.84e-05	0.00272	CbGpPWpGaD
Valproic Acid—HDAC2—Chromatin modifying enzymes—CDK4—skin cancer	2.79e-05	0.00267	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.77e-05	0.00266	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—CSPG4—skin cancer	2.75e-05	0.00264	CbGpPWpGaD
Valproic Acid—SLC16A1—Cell surface interactions at the vascular wall—KRAS—skin cancer	2.73e-05	0.00262	CbGpPWpGaD
Valproic Acid—ALDH5A1—Neuronal System—HRAS—skin cancer	2.67e-05	0.00255	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—FOXO4—skin cancer	2.65e-05	0.00253	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PLIN2—skin cancer	2.64e-05	0.00253	CbGpPWpGaD
Valproic Acid—ABAT—Transmission across Chemical Synapses—HRAS—skin cancer	2.64e-05	0.00253	CbGpPWpGaD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—TP53—skin cancer	2.58e-05	0.00247	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—ENO2—skin cancer	2.57e-05	0.00246	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—ERCC2—skin cancer	2.41e-05	0.00231	CbGpPWpGaD
Valproic Acid—CYP2C8—Arachidonic acid metabolism—PTGS2—skin cancer	2.39e-05	0.00229	CbGpPWpGaD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—IL6—skin cancer	2.37e-05	0.00227	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—PTGS2—skin cancer	2.36e-05	0.00226	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PLIN2—skin cancer	2.35e-05	0.00225	CbGpPWpGaD
Valproic Acid—SLC16A1—Cell surface interactions at the vascular wall—HRAS—skin cancer	2.32e-05	0.00223	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—SHH—skin cancer	2.27e-05	0.00218	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—RASA1—skin cancer	2.26e-05	0.00216	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—ENO2—skin cancer	2.24e-05	0.00215	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PLIN2—skin cancer	2.19e-05	0.0021	CbGpPWpGaD
Valproic Acid—HDAC2—Cell Cycle—TP53—skin cancer	2.17e-05	0.00208	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—SMO—skin cancer	2.15e-05	0.00206	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—PTCH1—skin cancer	2.15e-05	0.00206	CbGpPWpGaD
Valproic Acid—CYP2C19—Arachidonic acid metabolism—PTGS2—skin cancer	2.14e-05	0.00205	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—CSPG4—skin cancer	2.13e-05	0.00204	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—PTGER4—skin cancer	2.1e-05	0.00201	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CSPG4—skin cancer	2.07e-05	0.00198	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NOTCH—TP53—skin cancer	2.06e-05	0.00197	CbGpPWpGaD
Valproic Acid—ABAT—Neuronal System—HRAS—skin cancer	2.02e-05	0.00194	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—BRAF—skin cancer	1.98e-05	0.00189	CbGpPWpGaD
Valproic Acid—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	1.95e-05	0.00186	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PLIN2—skin cancer	1.92e-05	0.00184	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PTCH2—skin cancer	1.91e-05	0.00183	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—CSPG4—skin cancer	1.9e-05	0.00182	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—ERCC2—skin cancer	1.89e-05	0.00181	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—ENO2—skin cancer	1.87e-05	0.00179	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PLIN2—skin cancer	1.86e-05	0.00179	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—FOXO4—skin cancer	1.85e-05	0.00177	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.79e-05	0.00172	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	1.78e-05	0.0017	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—CSPG4—skin cancer	1.77e-05	0.00169	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—TERT—skin cancer	1.77e-05	0.00169	CbGpPWpGaD
Valproic Acid—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—skin cancer	1.72e-05	0.00165	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—PTGS2—skin cancer	1.7e-05	0.00163	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—TP53—skin cancer	1.68e-05	0.00161	CbGpPWpGaD
Valproic Acid—CYP1A2—Arachidonic acid metabolism—PTGS2—skin cancer	1.66e-05	0.00159	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.6e-05	0.00153	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—CSPG4—skin cancer	1.55e-05	0.00148	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PLIN2—skin cancer	1.52e-05	0.00145	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—CSPG4—skin cancer	1.5e-05	0.00144	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—ERCC2—skin cancer	1.49e-05	0.00143	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.46e-05	0.0014	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—GLI2—skin cancer	1.45e-05	0.00139	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—PTGS2—skin cancer	1.45e-05	0.00139	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—ENO2—skin cancer	1.45e-05	0.00138	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—ENO2—skin cancer	1.41e-05	0.00135	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—SHH—skin cancer	1.41e-05	0.00135	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—BRAF—skin cancer	1.4e-05	0.00134	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	1.38e-05	0.00133	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MC1R—skin cancer	1.38e-05	0.00132	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—GLI1—skin cancer	1.36e-05	0.00131	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—ERCC2—skin cancer	1.3e-05	0.00125	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SUFU—skin cancer	1.29e-05	0.00124	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—ENO2—skin cancer	1.29e-05	0.00123	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—IL6—skin cancer	1.28e-05	0.00123	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—TP53—skin cancer	1.26e-05	0.00121	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.25e-05	0.00119	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—NRAS—skin cancer	1.24e-05	0.00119	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TERT—skin cancer	1.24e-05	0.00119	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PLIN2—skin cancer	1.24e-05	0.00118	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CSPG4—skin cancer	1.22e-05	0.00117	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—ENO2—skin cancer	1.2e-05	0.00115	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	1.19e-05	0.00114	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PLIN2—skin cancer	1.17e-05	0.00112	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—IL6—skin cancer	1.15e-05	0.00111	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—FOXO4—skin cancer	1.15e-05	0.0011	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—PTGS2—skin cancer	1.13e-05	0.00108	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—ERCC2—skin cancer	1.09e-05	0.00104	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—KRAS—skin cancer	1.07e-05	0.00102	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—ENO2—skin cancer	1.05e-05	0.00101	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—ENO2—skin cancer	1.02e-05	0.000979	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	1.01e-05	0.00097	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CSPG4—skin cancer	9.96e-06	0.000954	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SHH—skin cancer	9.85e-06	0.000944	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—BRAF—skin cancer	9.8e-06	0.000939	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—RASA1—skin cancer	9.79e-06	0.000938	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PLIN2—skin cancer	9.43e-06	0.000903	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CSPG4—skin cancer	9.42e-06	0.000902	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PTCH1—skin cancer	9.34e-06	0.000895	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SMO—skin cancer	9.34e-06	0.000895	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PLIN2—skin cancer	9.21e-06	0.000882	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—HRAS—skin cancer	9.1e-06	0.000871	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PTGER4—skin cancer	9.09e-06	0.000871	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—PTGS2—skin cancer	8.94e-06	0.000856	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—ERCC2—skin cancer	8.8e-06	0.000843	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—NRAS—skin cancer	8.79e-06	0.000842	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—IL6—skin cancer	8.71e-06	0.000834	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—NRAS—skin cancer	8.61e-06	0.000825	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—ERCC2—skin cancer	8.4e-06	0.000804	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ENO2—skin cancer	8.3e-06	0.000795	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—ERCC2—skin cancer	8.17e-06	0.000783	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—FOXO4—skin cancer	8.03e-06	0.000769	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PLIN2—skin cancer	7.98e-06	0.000764	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—NRAS—skin cancer	7.88e-06	0.000754	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PTGS2—skin cancer	7.81e-06	0.000748	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—TERT—skin cancer	7.66e-06	0.000734	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CSPG4—skin cancer	7.6e-06	0.000728	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—KRAS—skin cancer	7.57e-06	0.000725	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—ERCC2—skin cancer	7.48e-06	0.000717	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CSPG4—skin cancer	7.43e-06	0.000711	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—KRAS—skin cancer	7.41e-06	0.00071	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PLIN2—skin cancer	7.12e-06	0.000682	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—ERCC2—skin cancer	6.98e-06	0.000669	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—KRAS—skin cancer	6.78e-06	0.000649	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ENO2—skin cancer	6.77e-06	0.000648	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TP53—skin cancer	6.59e-06	0.000631	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PTGS2—skin cancer	6.52e-06	0.000625	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PLIN2—skin cancer	6.49e-06	0.000622	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.49e-06	0.000622	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—HRAS—skin cancer	6.43e-06	0.000616	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CSPG4—skin cancer	6.43e-06	0.000616	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ENO2—skin cancer	6.4e-06	0.000613	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—HRAS—skin cancer	6.3e-06	0.000603	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—NRAS—skin cancer	6.16e-06	0.00059	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—IL6—skin cancer	6.16e-06	0.00059	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—ERCC2—skin cancer	6.1e-06	0.000584	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—BRAF—skin cancer	6.07e-06	0.000581	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TP53—skin cancer	6.03e-06	0.000577	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—ERCC2—skin cancer	5.94e-06	0.000568	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—HRAS—skin cancer	5.76e-06	0.000552	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CSPG4—skin cancer	5.74e-06	0.00055	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PLIN2—skin cancer	5.55e-06	0.000532	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TERT—skin cancer	5.37e-06	0.000514	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—KRAS—skin cancer	5.3e-06	0.000508	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.29e-06	0.000507	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CSPG4—skin cancer	5.24e-06	0.000501	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ENO2—skin cancer	5.16e-06	0.000495	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ENO2—skin cancer	5.05e-06	0.000483	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PTGS2—skin cancer	5.04e-06	0.000482	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PTGS2—skin cancer	4.9e-06	0.000469	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ERCC2—skin cancer	4.82e-06	0.000462	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TP53—skin cancer	4.71e-06	0.000451	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HRAS—skin cancer	4.51e-06	0.000431	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PTGS2—skin cancer	4.49e-06	0.00043	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CSPG4—skin cancer	4.47e-06	0.000428	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ENO2—skin cancer	4.37e-06	0.000419	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IL6—skin cancer	4.31e-06	0.000413	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PLIN2—skin cancer	4.28e-06	0.00041	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—BRAF—skin cancer	4.25e-06	0.000407	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PTGS2—skin cancer	4.19e-06	0.000401	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ERCC2—skin cancer	3.93e-06	0.000377	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ENO2—skin cancer	3.9e-06	0.000374	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—NRAS—skin cancer	3.81e-06	0.000365	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ERCC2—skin cancer	3.72e-06	0.000356	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTGS2—skin cancer	3.66e-06	0.00035	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTGS2—skin cancer	3.56e-06	0.000341	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ENO2—skin cancer	3.56e-06	0.000341	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CSPG4—skin cancer	3.45e-06	0.000331	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.42e-06	0.000327	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—KRAS—skin cancer	3.28e-06	0.000314	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.05e-06	0.000292	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ENO2—skin cancer	3.04e-06	0.000291	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ERCC2—skin cancer	3e-06	0.000287	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ERCC2—skin cancer	2.93e-06	0.000281	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTGS2—skin cancer	2.89e-06	0.000277	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HRAS—skin cancer	2.79e-06	0.000267	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.78e-06	0.000267	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NRAS—skin cancer	2.67e-06	0.000256	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—IL6—skin cancer	2.67e-06	0.000256	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ERCC2—skin cancer	2.54e-06	0.000243	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.38e-06	0.000228	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTGS2—skin cancer	2.36e-06	0.000226	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ENO2—skin cancer	2.35e-06	0.000225	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KRAS—skin cancer	2.3e-06	0.00022	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ERCC2—skin cancer	2.27e-06	0.000217	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTGS2—skin cancer	2.23e-06	0.000214	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ERCC2—skin cancer	2.07e-06	0.000198	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—skin cancer	2.04e-06	0.000196	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HRAS—skin cancer	1.95e-06	0.000187	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL6—skin cancer	1.87e-06	0.000179	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTGS2—skin cancer	1.8e-06	0.000172	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ERCC2—skin cancer	1.77e-06	0.000169	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTGS2—skin cancer	1.76e-06	0.000168	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTGS2—skin cancer	1.52e-06	0.000146	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ERCC2—skin cancer	1.36e-06	0.000131	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTGS2—skin cancer	1.36e-06	0.00013	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTGS2—skin cancer	1.24e-06	0.000119	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTGS2—skin cancer	1.06e-06	0.000101	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTGS2—skin cancer	8.17e-07	7.83e-05	CbGpPWpGaD
